Marijuana Moment June 12, 2024

Bipartisan Calif. Senators File Bill to Create Psilocybin Pilot Program for Veterans and First Responders

The move comes weeks after a Senate committee effectively killed a broader bill that would have legalized psychedelic service centers where adults 21 and older could have accessed psilocybin, MDMA, mescaline and DMT in a supervised environment with trained facilitators.

New York Times June 11, 2024

FDA Warns Against ‘Microdosing’ Mushroom Chocolate Bars Linked to Severe Illnesses

At least eight people have fallen ill after eating Diamond Shruumz products, including several who had seizures or needed to be put on ventilators.

Big Think June 10, 2024

How Psychedelics Could Help Silence Chronic Pain

Psychedelics show promise in treating chronic pain in ways that resemble their power to treat depression and other mental illnesses: They shake up the brain’s well-trodden neural pathways.

Marijuana Moment June 6, 2024

Ahead of Hearing on New Jersey Psilocybin Bill, Majority of Voters Back Legalization

The poll, from Stockton University’s William J. Hughes Center for Public Policy, found that 55 percent of respondents support legalizing psilocybin for medical use with a under doctor’s supervision. Just 20 percent of respondents were opposed, while 24 percent said they weren’t sure.

CNN June 5, 2024

FDA Advisers Vote Against First MDMA Therapy to Treat PTSD

Only one committee member said that the benefits of the treatment outweigh the risks as presented, but the other 10 voted that they did not.

Psychedelic Alpha June 3, 2024

ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws in 14-1 Vote

Unsurprisingly, a major area of concern for ICER, and NE-CEPAC, was the de facto unblinding of participants and study therapists in the two Phase 3 studies.

Axios June 3, 2024

Landmark Review Spotlights Challenge of Judging Psychedelic Therapies

The challenges of mainstreaming psychedelic therapies for conditions like PTSD, anxiety and major depression will be brought home this week when federal drug advisers scrutinize what could be the first such treatment to gain approval in the U.S.

WCAX May 31, 2024

What Does Passage of Vermont Psychedelic Mushroom Law Mean?

Vermont Gov. Phil Scott on Wednesday signed into law a bill that could put Vermont on the path to decriminalizing the use of psychedelic mushrooms.

San Francisco Chronicle May 30, 2024

‘It’s Just Crickets’: Why Efforts to Legalize Mushrooms in California Can’t Gain Traction

As a former Army Ranger, Jesse Gould is used to lawmakers thanking him for his service. But those good wishes sound hollow after Sacramento legislators spiked a proposal to legalize psychedelics for therapeutic purposes that could have helped veterans PTSD and other ailments.

Psychedelic Alpha May 30, 2024

Patients, Practitioners, Researchers and Public Submit Comments Ahead of FDA Advisory Committee on MDMA

In less than a week, an FDA advisory committee will meet to discuss Lykos Therapeutics’ MDMA-assisted therapy for PTSD. Last month, the agency established a docket and issued a request for comments from the public.

Marijuana Moment May 29, 2024

Atlanta Could Add Psilocybin and Ketamine to City Workers’ Healthcare Plans Under Pending Resolution

A new proposal from an Atlanta City Council member would direct municipal officials to explore the pros and cons of adding coverage for psilocybin and ketamine as mental health treatments to the city’s healthcare plan for firefighters, police and other government workers.

Psychedelic Alpha May 28, 2024

What to Expect: FDA Advisory Committee Set to Review MDMA-Assisted Therapy for PTSD

Next week, the FDA’s Psychopharmacologic Drugs Advisory Committee (PDAC) will meet to discuss Lykos Therapeutics’ MDMA-assisted therapy for PTSD New Drug Application (NDA).

High Times May 28, 2024

Atlanta Lawmaker Pushes City to Study Psilocybin, Ketamine Treatments

The councilmember, Liliana Bakhtiari, believes that health plans for city workers should include the treatments, which research has shown to be effective in combating mental health disorders such as PTSD.

Daily Hampshire Gazette May 28, 2024

Push to Legalize Psychedelics in Massachusetts Met with Caution

A ballot initiative and a proposed substitute version are pushing for the legalization of psychedelics in Massachusetts within the next year, but opponents said “it’s too premature.”

Marijuana Moment May 23, 2024

New York Bill Would Legalize Psilocybin Service Centers

The legislation, sponsored by Assembly Health Committee Chair Amy Paulin (D), is one of the latest examples of New York legislators moving to enact psychedelics reform amid a growing state-by-state movement across the country.

Hospice News May 22, 2024

Laws in Motion to Bring ‘Right to Try’ Psychedelics at End-of-Life

Hospice providers are navigating an evolving landscape of laws opening up pathways of access around psychedelic utilization at the end of life.

High Times May 21, 2024

Marital Status Uniquely Affects Psychedelic Experiences, Study Shows

As it turns out, your marital status could affect the extent to which psychedelics can lower your stress levels. And it appears that single folk may experience the greatest benefit of psychedelics.

Psychedelic Alpha May 18, 2024

California’s Latest Psychedelics Bill Dies in Committee

The bill would have established regulated, licensed psychedelic services in the state, replete with a Board of Regulated Psychedelic Facilitators and a Division of Regulated Psychedelic-Assisted Therapy.

MSN May 16, 2024

First responders, veterans hail benefits of psychedelic drugs as California debates legalization

A bill working its way through the California Legislature, would allow the therapeutic use of psilocybin; mescaline; MDMA, the active ingredient in ecstasy; and DMT, the active ingredient in ayahuasca, a plant-based psychoactive tea.

Marijuana Moment May 14, 2024

Top VA Official Says Psychedelics Have ‘Surpassed’ Marijuana In Bipartisan Acceptance in Congress

A top official with the U.S. Department of Veterans Affairs says there’s an “unstoppable narrative” in support of advancing psychedelic medicine, with a combination of compelling personal stories of recovery and robust clinical data from studies he’s hoping to expand upon.